Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Share News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 9.00
Ask: 9.50
Change: -0.65 (-6.74%)
Spread: 0.50 (5.556%)
Open: 9.50
High: 10.20
Low: 9.00
Prev. Close: 9.00
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

Wed, 02nd Jun 2021 16:02

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News:

----------

Sancus Lending Group Ltd - Guernsey-based alternative property finance - Andy Whelan resigns as chief executive officer, leaving on June 30, when he will be replaced by Rory Mepham as interim CEO. Mepham currently is in charge of funding and origination, having joined the company in January. Dan Walker, who currently is chief operating officer and managing director of Sancus UK, will become deputy CEO. Walker joined the company in 2018 from Lloyds Banking Group PLC, where he was director of Strategic Transactions. The changes follow refinancing and restructuring at Sancus, including renaming itself from GLI Finance Ltd, which was approved by shareholders earlier this month. This is to reflect its focus on the property bridging and development finance activities of the Sancus subsidiary.

----------

Cambridge Cognition Holdings PLC - Cambridge, England-based neuroscience technology - Adds Chief Financial Officer Mick Holton to board as executive director, effective immediately. Holton joined Cambridge Cognition in January from Biome Technologies PLC, where he was interim CFO. He previously worked for what is now Walgreens Boots Alliance Inc.

----------

Dispersion Holdings PLC - investor in decentralised finance, which uses blockchain and cryptocurrencies to remove financial intermediaries from transactions - Adds CFO Nick Lyth to board, effective immediately. Dispersion listed on Aquis Stock Exchange in late April, raising GBP9 million in its initial public offering and GBP2.2 million in pre-IPO fundraisings.

----------

e-Therapeutics PLC - Oxford, England-based drug discovery - Hires Alison Gallafent as head of Intellectual Property. Gallefent was head of IP at fellow AIM listing Silence Therapeutics PLC and also worked at Merck & Co Inc and Glaxo Wellcome.

----------

SDX Energy PLC - gas production in Egypt and exploration & development in Morocco - Amr Al Menhali will retire as director at annual general meeting on June 25, having left shareholder Waha Capital. Al Manhali had joined the SDX board back in September 2019, having been named CEO of Waha, which is SDX's largest shareholder, with a 19.5% stake.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Mar 2021 16:41

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma

Read more
1 Feb 2021 12:04

IN BRIEF: e-Therapeutics Says Tests Underway For GalNAc-siRNA Platform

IN BRIEF: e-Therapeutics Says Tests Underway For GalNAc-siRNA Platform

Read more
8 Dec 2020 20:38

IN BRIEF: e-Therapeutics Reports Results Of Covid-19 Compounds Testing

IN BRIEF: e-Therapeutics Reports Results Of Covid-19 Compounds Testing

Read more
12 Oct 2020 11:13

e-Therapeutics Names New Chief Executive; Plans To Ramp Up Research

e-Therapeutics Names New Chief Executive; Plans To Ramp Up Research

Read more
12 Oct 2020 10:06

e-Therapeutics 're-energised' by Mortazavi appointment

(Sharecast News) - Drug discovery and development company e-Therapeutics said on Monday that it was feeling "re-energised" by the addition of former Silence Therapeutics boss Ali Mortazavi amid active discussions with large pharmaceutical and biotechnology firms regarding potential collaborations.

Read more
8 Jul 2020 16:21

IN BRIEF: e-Therapeutics Bags GBP750,000 From Retail Offer

IN BRIEF: e-Therapeutics Bags GBP750,000 From Retail Offer

Read more
8 Jul 2020 10:45

UK WINNERS & LOSERS SUMMARY: HSBC Shares Fall Amid Investec Downgrade

UK WINNERS & LOSERS SUMMARY: HSBC Shares Fall Amid Investec Downgrade

Read more
7 Jul 2020 19:05

IN BRIEF: e-Therapeutics Plans GBP12 Million Fundraise

IN BRIEF: e-Therapeutics Plans GBP12 Million Fundraise

Read more
10 Jun 2020 13:15

UK TRADING UPDATE SUMMARY: XLMedia To Sell Finnish Casino Assets

UK TRADING UPDATE SUMMARY: XLMedia To Sell Finnish Casino Assets

Read more
10 Jun 2020 09:20

E-therapeutics enters collaboration deal with Galapagos

(Sharecast News) - E-therapeutics has entered a collaboration agreement with Galapagos to identify new therapeutic approaches to modulate a specific mechanism involved in idiopathic pulmonary fibrosis (IPF), and potentially in other fibrotic indications, it announced on Wednesday.

Read more
26 May 2020 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
18 May 2020 10:51

UK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"

UK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"

Read more
2 Apr 2020 13:07

UK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor

UK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor

Read more
17 Mar 2020 15:10

e-Therapeutics Loss Narrows On Higher Revenue And Lower R&D Spend

e-Therapeutics Loss Narrows On Higher Revenue And Lower R&D Spend

Read more
11 Feb 2020 13:25

e-Therapeutics Reshuffles Board, Issues 53.3 Million Shares

e-Therapeutics Reshuffles Board, Issues 53.3 Million Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.